Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06471504 · ClinicalTrials.gov registry record · NA
Use of Eye Tracking to Aid in Autism Risk Detection
A NA study of Autism, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06471504: Recruiting NA study of Autism, sponsored by Indiana University.
NCT06471504 is a NA study of Autism that is actively recruiting participants, run by Indiana University. The registered enrollment target is 100 participants, below the 182-participant average among 104 other Autism trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06471504, a NA study of Autism, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.
Primary Outcome
The composite eye-tracking biomarker score, a consolidated measure based on eye-tracking indices that predict autism outcome, will be compared to the categorical autism diagnosis (autism presence/absence). Clinical diagnosis is obtained based upon a standard clinical evaluation conducted by an expert clinical psychologist. The evaluation will include 1) a semi-structured caregiver(s) clinical interview to gather information about developmental history and autism symptoms and 2) a battery of stan
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Eyelink Portable Duo
Study Locations (1)
Indiana
- Riley Hospital for Children - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-08 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT06471504 shows while recruiting
NCT06471504 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 182-participant average among 104 other Autism trials with a reported enrollment target (45% lower).
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Eyelink Portable Duo is the first listed.
NCT06471504 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06471504 about?
NCT06471504 is a clinical study titled "Use of Eye Tracking to Aid in Autism Risk Detection". The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.
What is the current status of trial NCT06471504?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-08. Estimated completion is 2026-04-30.
What conditions does trial NCT06471504 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT06471504?
The interventions under investigation include: Eyelink Portable Duo (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06471504?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06471504 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06471504's enrollment target sits among peer trials
100 38th of 104 higher than 64 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Evaluating Pathways Mutual Gaze Protocol on Social Skills in Young Children Suspected of Autism
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI